ARCH Venture Partners is a venture capital firm in Illinois that focuses on life science discoveries to prevent, detect and cure disease. Founded 1986 in Chicago, Illinois, United States by Clinton Bybee, Keith Crandell, Robert Nelsen and Steven Lazarus, it invests in early stage ventures, seed, series B, series A, series C, and post-IPO equity. Its portfolio companies include Volastra Therapeutics, Sonoma BioTherapeutics, Vizgen, EQRx, and Omniome. As of April 2020, ARCH Venture Partners has made 321 investments. Their most recent investment was on February 11, 2020, when Volastra Therapeutics raised $12M. ARCH Venture Partners has had 69 exits, the most notable of which include Twist Bioscience, Alnylam Pharmaceuticals, and Juno Therapeutics. The company has raised 10 funds, their latest being ARCH Venture Fund X. This fund was announced on October 25, 2019 and raised a total of $635.8M.
A DNA synthesis company using a next-generation silicon-based technology platform.
Illumina is a biotechnology company founded in 1998 located in San Diego, California, developing and selling instruments, reagents, and services for DNA sequencing applications.
Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
Designs and manufactures nanotechnology materials to improve display color performance and batteries
A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.
A company developing therapies for the treatment of cancer and immune disorders
Nebula Genomics is a genetics company developing a platform for individuals to get their personal genome sequenced, and then enable them to store and control that information through cryptographic encryption on the blockchain.
Codiak Biosciences is a biotechnology company developing exosome therapeutics.
A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.
A company developing gene therapies for the treatment of genetic diseases and cancer.
Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.
A biotechnology company using photosynthetic organisms to make renewable solutions.
Crystal IS manufactures high-performance deep UV (UVC) LEDs for water and surface disinfection, monitoring, and sterilization applications in a variety of industries.
A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.
Aira is a computer vision connected devices virtual reality (VR) and augmented reality (AR) company developing tools for the visually impaired. Aira.IO is a wearable device to help the visually impaired gain more mobility and independence.
Nohla Therapeutics is a biotechnology company developing universal donor cell therapies.
Luna DNA is company providing a marketplace for genetic data using blockchain based data storage.
Associated investment funds
Documentaries, videos and podcasts